
New real-world studies show Vraylar boosts depression relief, functioning, and quality of life in MDD and bipolar I patients beyond clinical trials.
Patients with bipolar disorder experience a substantial burden of medical and psychiatric comorbidities. A recent study in the British Journal of Psychiatry sheds light on the most prevalent medical conditions among persons with bipolar disorder.
Which of these was not one of the most common conditions in patients with BP?